Director / Senior Director, Regulatory Affairs Advertising & Promotion
Quick Summary
Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies.
Position Overview
Immunome is seeking a highly experienced and strategic Director / Senior Director, Regulatory Affairs Advertising & Promotion to provide regulatory leadership for U.S. advertising, promotional labeling, and medical communications across our oncology portfolio. This role will partner with Commercial, Medical Affairs, Legal, and Compliance to enable compliant and competitive communication strategies from early launch planning through post-launch execution.
The successful candidate will bring deep expertise in FDA advertising and promotion regulations and OPDP practices, strong judgment and risk-based decision making, and proven leadership in medical-legal-regulatory review environments. This position offers an opportunity to build Immunome’s Advertising & Promotion capabilities as we prepare for and execute commercial launches.
Responsibilities
Requirements
~1 min readImmunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish).
Location & Eligibility
Listing Details
- Posted
- June 17, 2026
- First seen
- June 18, 2026
- Last seen
- June 18, 2026
Posting Health
- Days active
- 0
- Repost count
- 0
- Trust Level
- 79%
- Scored at
- June 18, 2026
Signal breakdown
Please let Immunomeinc know you found this job on Jobera.
3 other jobs at Immunomeinc
View all →Explore open roles at Immunomeinc.
Similar Regulatory Affairs jobs
View all →Browse Similar Jobs
Stay ahead of the market
Get the latest job openings, salary trends, and hiring insights delivered to your inbox every week.
No spam. Unsubscribe at any time.